|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Interest earned on investments securities held in Trust Account | |||||
| Discount amortization on convertible notes | |||||
| Gain on note repurchase | |||||
| Loss on asset disposal | |||||
| Non-cash interest expense | |||||
| Loss on debt extinguishment | |||||
| Depreciation and amortization | |||||
| Discount amortization on convertible note | |||||
| Amortization of debt financing costs | |||||
| Stock-based compensation expense | |||||
| Credit loss expense | |||||
| Convertible note impairment | |||||
| Abandoned software implementation assets | |||||
| Accrued interest on convertible notes | |||||
| Amortization of operating lease right of use assets | |||||
| Change in fair value of warrants | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Contract assets | |||||
| Accounts payable and other liabilities | |||||
| Operating lease liabilities | |||||
| Deferred payroll tax credits | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of convertible note | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Business combination, net of transaction cost | |||||
| Proceeds from the issuance of convertible notes | |||||
| Proceeds from the issuance of term notes | |||||
| Proceeds from short-term cash advances | |||||
| Repayment of short-term cash advances | |||||
| Proceeds from related party payable | |||||
| Repayment of related party payable | |||||
| Cost of convertible and term note issuance | |||||
| Proceeds from issuance of common stock | |||||
| Cost of equity issuance | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of the period | |||||
| Cash and cash equivalents, at end of the period | |||||
| Supplemental cash flows disclosures | |||||
| Income taxes paid | |||||
| Interest paid | |||||
| Non-cash investing and financing activities | |||||
| Amount added to principal for non-cash interest on and non-cash amendment to Convertible Notes | |||||
| Legal settlements satisfied through issuance of common stock | |||||
| Satisfaction of professional services through issuance of common stock | |||||
| Common stock issued for services rendered relating to debt financing | |||||
| Amount added to principal for non-cash interest on and non-cash amendment to Convertible Notes | |||||
| Obtaining a right-of-use asset in exchange for a lease liability | |||||
| Common stock issued for services rendered | |||||
| Settlement of litigation through issuance of common stock | |||||
| Related party payments on accounts payable | |||||
| Conversion of convertible note and outstanding interest into common stock | |||||
| Warrants assumed in business combination at estimated fair value | |||||
| Conversion of L1 Notes into common stock | |||||
| Common stock issued in connection with the acquisition of ViceCRM | |||||
| Right-of-use asset derecognized in connection with early lease termination | |||||
Loading...